Delhi High Court Seeks Centre's Response on HPV Vaccine Safety Concerns
The Delhi High Court has raised serious concerns over the Centre's rollout of Merck's Gardasil HPV vaccine under the Universal Immunisation Programme, following a PIL filed by Dr Sujata Mittal and Jitendra Chouksey. The petition cites past adverse events, including deaths linked to 2009 clinical trials in Andhra Pradesh, and questions the vaccine's safety, informed consent, and monitoring of side effects. The court has sought responses from the Centre, ICMR, and CDSCO, emphasizing caution while acknowledging the vaccine's role in preventing cervical cancer. The next hearing is scheduled for July 29.
First-hand measurement across 4 sources
We measured how 4 outlets covered this story. Coverage leans centre-left overall (Left 57%, Centre 43%, Right 0%). Overall sentiment is neutral (45/100). Lens Score 68/100.
Outlets measured: moneycontrol, businessstandard, news18, indianexpress. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
All 1 outlets scored close to centre on political lean. The real divergence here is in emphasis, not lean — compare the headlines below to see how each outlet chose to frame the same facts.
Sentiment was consistent across outlets (35–50/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
indianexpress broke this story on 22 Jul, 10:38 am. Other outlets followed.